Amgen (AMGN) Notes Payables (2009 - 2014)

Amgen's Notes Payables history runs 5 years deep, the most recent figure standing at $2.5 billion for Q1 2014.

• In Q1 2014, Notes Payables rose 35685.71% year-over-year to $2.5 billion; the TTM figure through Mar 2014 stood at $2.5 billion (up 35685.71% YoY), while the FY2013 annual figure was $2.5 billion, changed 0.4% from the prior year.
• Notes Payables was $2.5 billion for Q1 2014 at Amgen, roughly flat from $2.5 billion in the prior quarter.
• In the past five years, Notes Payables ranged from a high of $2.5 billion in Q4 2013 to a low of $7.0 million in Q1 2013.
• Historically, Notes Payables has averaged $1.2 billion across 4 years, with a median of $300.0 million in 2011.
• The sharpest annual moves came in 2013 and 2014: Notes Payables sank 99.55% in 2013, then jumped 35685.71% in 2014.
• A 4-year view of Notes Payables shows it stood at $84.0 million in 2011, then jumped by 2870.24% to $2.5 billion in 2012, then increased by 0.4% to $2.5 billion in 2013, then changed by 0.0% to $2.5 billion in 2014.
• The last three Notes Payables figures came in at $2.5 billion (Q1 2014), $2.5 billion (Q4 2013), and $11.0 million (Q3 2013), per Business Quant data.